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Previous reports from our lab have shown that Skp2 is necessary for p27 degradation and cell cycle
progression during adipocyte differentiation. Data presented here demonstrate that the anti-in-
ﬂammatory, anti-obesity phytochemical curcumin blocked Skp2 protein accumulation during early
adipocyte hyperplasia. In addition, curcumin dose-dependently induced p27 protein accumulation and
G1 arrest of synchronously replicating 3T3-L1 preadipocytes. Of note, p27 protein accumulation occurred
in the presence of decreased p27 mRNA suggesting a role for post-transcriptional regulation. In support
of this hypothesis, curcumin markedly increased p27 protein half-life as well as attenuated ubiquitin
proteasome activity suggesting that inhibition of targeted p27 proteolysis occurred through curcumin-
mediated attenuation of Skp2 and 26S proteasome activity. While we observed no cytotoxic effects for
curcumin at doses less than 20 mM, it is important to note an increase in apoptotic signaling at con-
centrations greater than 30 mM. Finally, data presented here demonstrate that the anti-proliferative effect
of curcumin was critical for the suppression of adipocyte differentiation and the development of the
mature adipocyte. Collectively, our data demonstrate that curcumin-mediated post-transcriptional ac-
cumulation of p27 accounts in part for the anti-proliferative effect observed in 3T3-L1 preadipocytes.
& 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Obesity-associated co-morbidities such as diabetes and cardi-
ovascular disease contribute to the rising incidence of morbidity
and mortality as well as add to the tremendous burden plaguing
our health care system [19,43]. Obesity is deﬁned as excess white
adipose tissue accumulation that can occur due to increased adi-
pocyte cell volume (hypertrophy) and cell number (hyperplasia).
Though preadipocyte (PA) replication slows during adulthood,
periods of positive energy balance at any age can trigger pro-
liferation and subsequent differentiation of dormant PAs known to
exist throughout the lifespan [5,15,18,32]. Obesity resulting from
adipocyte hyperplasia is associated with the poorest prognosis of
treatment [11,46]. Thus, understanding of molecular and cellular
events involved in adipogenesis is critical for elucidating targets in
the treatment and prevention of obesity and its co-morbidities.
The hormonal and nutritional mechanisms underlying adipo-
cyte hyperplasia have been extensively studied using the murine
3T3-L1 preadipocyte cell line [24]. In response to a standard adi-
pogenic cocktail, growth-arrested PAs synchronously re-enter theB.V. This is an open access article u
Stone Building UNC Green-
).cell cycle for 1–2 rounds of cell division known as mitotic clonal
expansion (MCE), a required and necessary step for adipogenesis
[26,40]. MCE is driven by the convergence of mitogen-dependent
signaling pathways on sequential expression of regulatory cyclin
proteins needed for cyclin-dependent kinase (Cdk) activation.
Timely activation of Cdks is critical for orderly cell cycle progres-
sion. Transition through the G1/S phase restriction point re-
presents a pivotal and decisive point of cellular autonomy where
cell cycle control becomes mitogen-independent [4,37,38]. Cell
cycle progression through this restriction point is potently sup-
pressed by the cyclin-dependent kinase inhibitor (CKI) p27 [7]. In
contrast to the mitogenic activation of cyclins, p27 accumulates in
response to anti-mitotic stimuli (e.g. nutrient deprivation, density-
arrest, differentiation) to ensure cell cycle arrest and extended
quiescence [14,28,30,31]. Indeed, p27 gene ablation has been
shown to markedly increase fat mass in mice due to adipocyte
hyperplasia [27]. Thus, molecular mechanisms that maintain an
optimal balance in p27 during PA replication appear critical in the
etiology of obesity.
Curcumin is a bioactive phytochemical found in the rhizome of
the perennial herb Curcuma longa Linn (turmeric). Widely used as
a culinary agent, curcumin is known to have anti-oxidant, anti-
inﬂammatory, and anti-carcinogenic properties [36,44]. Of note,
high doses of curcumin (12 g/day) have shown no signiﬁcant cy-
totoxic effects in humans demonstrating that curcumin is a safender the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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demonstrated an anti-inﬂammatory, anti-diabetic, and anti-obe-
sity role for curcumin in mouse models of obesity and diabetes
[10,35,45]. While these studies postulated a preventive role of
curcumin in diet-induced obesity, ﬁndings from Ejaz et al. [10]
demonstrated an inhibitory role for curcumin during adipocyte
differentiation. More recently, it was demonstrated that curcumin
blocks adipogenesis during early adipocyte differentiation by in-
hibiting post-conﬂuent PAs during MCE [17]. Despite these ﬁnd-
ings that suggest that curcumin is effective in regulating new
adipocyte generation, the mechanistic actions of curcumin during
adipogenesis remain unclear.
Previous reports from our lab have demonstrated that S-phase
kinase-associated protein-2 (Skp2) regulates p27 degradation
during S and G2 phase progression of replicating 3T3-L1 PAs
during early adipocyte differentiation [2,3]. Furthermore, we and
others have shown that Skp2 promotes cell cycle progression by
targeting speciﬁc proteins for ubiquitylation and degradation by
the 26S proteasome [2,6,39]. In this study, we demonstrated that
the inhibitory actions of curcumin on adipocyte differentiation
occur early during PA proliferation. Moreover, we demonstrated
that curcumin arrests proliferating PAs in late-G1 phase and pro-
motes p27 protein accumulation during density arrest by post-
transcriptional mechanisms involving Skp2 and 26S proteasome
degradation. Together, these data demonstrate an effect of curcu-
min on p27 protein accumulation and provide a link between cell
cycle progression and adipocyte hyperplasia.2. Materials and methods
2.1. Materials
Dulbecco's Modiﬁed Eagle's Medium (DMEM), calf bovine ser-
um (CS), and trypsin-EDTA were purchased from Invitrogen. Fetal
bovine serum (FBS) was obtained from HyClone. Propidium Iodide
was purchased from Sigma. The following antibodies used for
western blot analysis: p27 (Transduction Laboratories); Cleaved
caspase-3, cleaved PARP, and ubiquitin (Cell Signaling); and cyclin
A, PPARγ, C/EBPα, adipsin, and Skp2 (Santa Cruz Biotechnology).
Curcumin was purchased from Alexis Biochemical.
2.2. Cell Culture
Murine 3T3-L1 PAs, purchased from Howard Green, Harvard
Medical School, were cultured and differentiated as previously
described [2]. Brieﬂy, cells were propagated in DMEM supple-
mented with 10% CS until density-arrest at 2 days post-conﬂuence
then stimulated a hormonal cocktail containing 10% FBS, 0.5 mM
1-methyl-3-isobutylxanthine, 1 mM dexamethasone, and 1.7 mM
insulin (MDI). Time post-MDI refers to the time since the admin-
istration of MDI to culture medium.
2.3. Immunoblotting
Relative protein abundance was assessed by immunoblotting as
previously described [2].
2.4. Oil Red O (ORO)
Cells were ﬁxed in formalin and stained with ORO, washed in
deionized water, dried and scanned for analysis.
2.5. Flow cytometry
Cell cycle progression was assessed by DNA histogramsgenerated by propidium iodide staining as previously described
[2].
2.6. Real-Time RT-PCR
Relative mRNA abundance was assessed by RT-PCR using the
−ΔΔ2 CT method as previously described [12].
2.7. Proteasome assay
Proteasome activity was assessed using the 20S Proteasome
Assay Kit per manufacturer's instructions (BostonBiochem, Cam-
bridge, MA).3. Results
3.1. Curcumin inhibits 3T3-L1 adipocyte differentiation during early
stages of adipogenesis
To examine the effects of curcumin on adipocyte differentia-
tion, density-arrested PAs were dose-dependently treated with
curcumin and stimulated to differentiate with MDI. On day 8 (d8),
cells were ﬁxed and stained with Oil Red O (ORO) to assess lipid
accumulation. As shown by ORO, curcumin dose-dependently in-
hibited adipocyte differentiation (Fig. 1A). Inhibition of differ-
entiation resulted from suppression of PPARγ and C/EBPα, the
dominant transcriptional regulators of adipogenesis (Fig. 1B).
Mitotic clonal expansion (MCE) is an ‘obligatory’ step of adi-
pocyte differentiation. Inhibition of MCE has been shown neces-
sary for the activation of PPARγ and C/EBPα and acquisition of the
mature adipocyte phenotype [24–26,33]. To elucidate a role for
curcumin during MCE, we treated density-arrested PAs in the
absence or presence of 20 mM curcumin at 0 h, 24 h, 48 h, or 72 h
post-MDI stimulation. For each treatment, protein expression was
assessed on day 8 (d8) for C/EBPα, PPARγ, and adipsin, an adipo-
cyte-speciﬁc serine protease. Compared to untreated PAs (d0),
MDI-stimulation led to marked increases in protein expression of
all three proteins (Fig. 1C). However, treatment with curcumin at
the onset of differentiation (0 h) suppressed protein expression of
C/EBPα, PPARγ, and adipsin, with only modest suppression ob-
served for curcumin treatment 24 h post-MDI and no effect seen
with treatment 48 h or 72 h post-MDI (Fig. 1C).
The ﬁndings demonstrated that curcumin blocked early stages
(o24 h) of adipocyte differentiation. To determine if curcumin
suppressed MCE, density-arrested PAs were stimulated with MDI
for 20 h in the absence or presence of increasing doses of curcu-
min. Cells were ﬁxed and DNA stained with propidium iodide for
ﬂow cytometric analysis of cell cycle progression. As shown in
Fig. 1D, two DNA peaks in the 2n and 4n range, representing G0/G1
and G2/M cell populations, were present in all histograms. Sti-
mulation with MDI resulted in a marked shift from G0/G1 to S and
G2/M phase populations demonstrating synchronous cell cycle
progression in the absence of curcumin (Fig. 1D). In contrast,
curcumin dose-dependently inhibited MDI-induced cell cycle
progression prior to G1/S phase transition (Fig. 1D).
Curcumin has been shown to induce apoptosis in various can-
cer cell lines [21,29], To assess cytotoxicity, density-arrested PAs
were stimulated with MDI for 20 h in the absence or presence of
increasing concentrations of curcumin or 1000 J/m2 UV, a known
activator of apoptosis. Protein expression was examined for cas-
pase 3 and PARP cleavage, mid- and late-stage markers of
apoptosis.
Fig. 1. Curcumin dose-dependently inhibits 3T3-L1 PA proliferation. PAs were stimulated with MDI and increasing concentrations of curcumin and stained with Oil red O at
day 8 post-MDI (A) to assess lipid accumulation and cell lysates immunoblotted (B) for key adipogenic transcription factors. (C) Growth-arrested 3T3-L1 PAs were stimulated
with MDI in the absence or presence of 20 mM curcumin at the onset of differentiation (0 h), 24 h post-MDI, 48 h post-MDI, or 72 h post-MDI. Cell lysates were harvested
8 days post-MDI and immunoblotted to assess adipocyte differentiation. (D) Density-arrested PAs were stimulated with MDI and increasing concentrations of curcumin. Cells
were ﬁxed at d0 and 20 h post-MDI and DNA stained with propidium iodide. DNA histograms were assessed via ﬂow cytometry. (E) Cell lysates were assessed for apoptosis
by immunoblotting for cleaved caspase 3 and PARP. Cell lysates treated with 1000 J/m2 UV were used as a positive control for apoptosis.
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To further elucidate the effect on cell cycle progression, den-
sity-arrested PAs were stimulated with MDI for 20 h in the ab-
sence or presence of increasing doses of curcumin. Cell lysates
were harvested and analyzed for inducible cyclin protein expres-
sion corresponding to speciﬁc phases of the cell cycle. Curcumin
dose-dependently suppressed cyclin A which is known to accu-
mulate and function during S phase progression [22,25]. To elu-
cidate if cell cycle arrest occurred in G0 or G1, lysates were also
immunoblotted for cyclin D1 which is known to accumulate andFig. 2. Curcumin inhibits p27 protein degradation during PA proliferation. (A) Density-a
Cell lysates were harvested 20 h post-MDI and immunoblotted for cell cycle protein expr
mRNA examined using real time qRT-PCR. Data were set relative to MDI-stimulated PA
niﬁcance was set at po0.05 as measured via ANOVAwith Tukey's post-hoc. (C) PAs were
were exposed to cycloheximide (CHX; 30 mM) to block protein synthesis. Lysates were h
digitized and liner regression of remaining protein abundance over time was assessedfunction during G1 phase progression [24,25]. As illustrated, cyclin
D1 increased with increasing concentrations of curcumin up
through 20 mM, yet was suppressed with 30 mM curcumin
(Fig. 2A). Collectively, these data suggest that doses o30 mM
curcumin block cells in G1 phase of the cell cycle.
Previous reports from our lab and others have shown that
transition across the G1/S restriction point involves p27 regulation
[2–4]. Therefore, we examined the effect of curcumin treatment on
p27 protein expression. Density-arrested PAs were stimulated as
indicated above and cell lysate harvested at d0 and 20 h to ex-
amine p27 protein expression. Consistent with a G1 phase arrest,rrested PAs were stimulated with MDI and increasing concentrations of curcumin.
ession. (B) RNA was also isolated from cells at 20 h post-MDI and curcumin and p27
s in the absence of curcumin (0 mM) and normalized to 18S rRNA. Statistical sig-
stimulated with MDI and increasing concentrations of curcumin. After 18 h, all cells
arvested over time post-CHX and immunoblotted for p27 decay. Immunoblots were
for protein half-life (t1/2).
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centration dependent manner (Fig. 2A). To elucidate a mechanism
of curcumin on p27 protein accumulation, we examined the effect
of curcumin on p27 mRNA expression. In contrast to p27 protein
accumulation, curcumin treatment suppressed p27 mRNA abun-
dance (Fig. 2B) suggesting a post-transcriptional role for curcumin
on p27 protein accumulation. Consistent with this hypothesis, we
observed a dose-dependent decrease in Skp2 protein accumula-
tion (Fig. 2A). Previous reports from our lab have shown that in-
creased Skp2 targets p27 for ubiquitylation and proteasome de-
gradation in adipocytes [2,3]. To determine a role for curcumin on
p27 protein stability, growth-arrested PAs were stimulated with
MDI for 18 h in the absence or presence of curcumin prior to ex-
posure to 30 mM cycloheximide (CHX) to block de novo protein
synthesis. Cell lysates were subsequently harvested over time
post-CHX and immunoblotted for p27. Linear regression of protein
remaining over time post-CHX was used for protein half-life (T1/2)
estimation. As shown (Fig. 2C), p27 protein half-life markedly in-
creased in response to curcumin (20 mM¼8.4 h; 30 mM¼11.2 h)
compared to MDI alone (0 mM¼3.8 h).
3.3. Curcumin inhibits proteasome activity
Data presented above suggested a role for curcumin on p27
regulated proteolysis via mechanisms involving SCFSkp2 E3 ligase
and 26S proteasome during PA proliferation. However, recent
studies have reported a role for curcumin in the direct regulation
of 26S proteasome activity [9,16,21]. To examine this, we utilized a
proteasome activity assay to measure chymotrypsin-like activity inFig. 3. Curcumin inhibits 20S proteasome activity and leads to increased accumulation o
with curcumin (20 mM) or epoxomicin (Epox; 1 mM) and spectral analysis used to exam
with MDI in the absence or presence of curcumin or Epox (1 mM). Cell lysates were co
positive control for proteasome inhibition. One-way ANOVA with Dunnet's post-hoc wa
expressed as SEM. (C) Immunblot analysis of cells collected 8 h post-MDI with increasing
(1 mM) was used as a positive control. (D) Proposed model for curcumin-mediated inhibvitro of puriﬁed 20S proteasome. Activated puriﬁed rabbit 20S
proteasome was incubated in the absence or presence of curcumin
or epoxomicin (Epox), a potent proteasome inhibitor, and protea-
some activity measured over time. Direct interaction with puriﬁed
20S proteasome revealed a potent role for curcumin (94%,
po0.05) on proteasome inhibition equivalent to Epox (97%,
po0.05) (Fig. 3A). We also determined that curcumin dose-de-
pendently attenuated proteasome activity in PAs. While 20 mM
(15%, po0.05) and 30 mM (35%, po0.05) curcumin presented
with a statistically signiﬁcant decrease in proteasome activity, its
effects were minimal compared to Epox (89%, po0.05) (Fig. 3B).
As 26S proteasome inhibition would be expected to yield in-
creased protein ubiquitylation, we next examined a role for cur-
cumin on ubiquitin protein expression. Density-arrested PAs were
stimulated with MDI in the absence or presence of increasing
doses of curcumin or 1 mM Epox and harvested 8 h post-MDI to
assess ubiquitin conjugates. As shown in Fig. 3C, curcumin in-
creased ubiquitin conjugate protein expression, consistent with its
inhibition of the proteasome.4. Discussion
This study deﬁnes curcumin as an anti-proliferative agent in
cultured 3T3-L1 PAs undergoing adipocyte differentiation. Further,
data presented here elucidate an early anti-adipogenic role for
curcumin via post-transcriptional regulation of p27. We propose a
model in which curcumin increases p27 protein half-life through
mechanisms involving both inhibition of Skp2 proteinf ubiquitylated proteins. (A) Puriﬁed 20S proteasome (0.2 mg/200 ml) was incubated
ine chymotrypsin-like protease activity. (B) Density-arrested PAs were stimulated
llected 20 h post-MDI and processed for proteasome activity. Epox was used as a
s used to determine signiﬁcance (n¼4, po0.05) compared to control and all data
concentrations curcumin were assessed for ubiquitylated protein conjugates. Epox
ition of PA proliferation.
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arrest (Fig. 3D).
Excess energy intake stimulates PA proliferation and differ-
entiation into mature adipocytes during the development of hy-
perplastic obesity [13,32]. The cyclin dependent kinase inhibitor
(CKI) p27 plays a critical role in the development of adipocyte
hyperplasia as a potent inhibitor of G1/S transition [30,31,42].
Other studies have shown that p27 null mice have excessive adi-
pose tissue mass due to adipocyte hyperplasia and not hyper-
trophy [27]. Using 3T3-L1 PAs, we had previously shown that
targeted p27 proteolysis was regulated by the SCFSkp2 E3 ligase
and 26S proteasome during PA proliferation [2,3]. Intriguingly,
Skp2 null mice are protected from genetic and diet-induced obe-
sity due to a decrease in adipocyte cell number [8,34]. Importantly,
decreased adipocyte number and fat pad mass of Skp2 null mice
was completely lost in Skp2 and p27 double knockout animals [8].
Collectively, these data suggest that optimal balance of p27 is
tightly controlled by the SCFSkp2 E3 ligase. Data presented here
demonstrated a dose-dependent increase in p27 protein accu-
mulation that tightly correlated with Skp2 suppression during PA
proliferation. Moreover, changes in p27 protein accumulation were
not the result of changes in mRNA expression. In support of Skp2-
mediated p27 degradation, we further showed that curcumin
markedly increased p27 protein stability, as p27 half-life more
than doubled in the presence of 20 mM curcumin.
Recent evidence has shown that curcumin can inhibit 26S
proteasome activity in cancer cells [9,16,21], suggesting another
route to increase p27 protein stability. Consistent with these re-
ports, we demonstrated a potent suppression of puriﬁed 20S
proteasome activity in vitro. However, curcumin only modestly
attenuated 20S activity in 3T3-L1 PAs. One postulate for the dif-
ferences in curcumin-mediated proteasome activity rely on the
well-known observation that curcumin is poorly soluble and
bioavailable [36,44]. However, it should be noted that 20 mM cur-
cumin was sufﬁcient in increasing protein ubiquitin conjugates in
3T3-L1 PAs, further supporting proteasome inhibition. Taken to-
gether, our data highlight two anti-proliferative mechanisms for
curcumin in 3T3-L1 PAs, where curcumin increased p27 protein
stability by (1) inhibiting Skp2-mediated p27 proteolysis and
(2) inhibiting proteasome-mediated p27 degradation.
In summary, early reports have demonstrated that curcumin
blocked adipocyte differentiation, but the underlying mechanisms
were not fully elucidated [20]. Since then, it has been proposed
that curcumin blocks adipocyte differentiation during an early
phase of PA replication known as MCE [17] and that this inhibition
potentially resulted from inhibition of Wnt signaling [1]. Our re-
sults demonstrated that curcumin potently blocked Skp2 protein
expression that was tightly correlated to the increase in p27 pro-
tein accumulation. Intriguingly, genetic loss of Wnt signaling has
been shown to increase p27 accumulation and cell cycle arrest
[23,41]. Moreover, inhibition of the Wnt pathway has been shown
to inhibit Skp2 expression and increase p27 accumulation [41].
Thus, future investigation into the role of curcumin on Wnt-
regulated p27 protein expression during early adipogenesis will be
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